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Many case-control tests of rare variation are implemented in statistical frameworks that make correction for confounders like population
stratification difficult. Simple permutation of disease status is unacceptable for resolving this issue because the replicate data sets do not
have the same confounding as the original data set. These limitations make it difficult to apply rare-variant tests to samples in which
confounding most likely exists, e.g., samples collected from admixed populations. To enable the use of such rare-variant methods in
structured samples, as well as to facilitate permutation tests for any situation in which case-control tests require adjustment for con-
founding covariates, we propose to establish the significance of a rare-variant test via a modified permutation procedure. Our procedure
uses Fisher’s noncentral hypergeometric distribution to generate permuted data sets with the same structure present in the actual data set
such that inference is valid in the presence of confounding factors. We use simulated sequence data based on coalescent models to show
that our permutation strategy corrects for confounding due to population stratification that, if ignored, would otherwise inflate the size
of a rare-variant test. We further illustrate the approach by using sequence data from the Dallas Heart Study of energy metabolism traits.
Researchers can implement our permutation approach by using the R package BiasedUrn.Introduction
Association mapping of rare variants (those with a minor
allele frequency [MAF] < 1%) and less-common variants
(those with a MAF between 1% and 5%) requires different
analytic methods from those typically used for the detec-
tion of common genetic variants in a genome-wide associ-
ation study (GWAS). For a case-control study, GWAS-based
statistical methods usually consider genetic variants
individually and develop an association test based on
allele-frequency differences of the variant between cases
and controls. For rare-variant analysis, this strategy will
most likely have inadequate power given that power
decreases with decreasing allele frequency for fixed sample
and effect sizes. Thus, many recent publications recom-
mend association tests that aggregate rare and less-
common variants within a gene or region for analysis.
Many ‘‘burden’’ tests pool such variants into a composite
variable and then test for association between that
composite variable and disease status. The composite vari-
able could be a binary indicator of whether a subject
possesses a rare variant (defined as a variant below some
allele-frequency threshold value) within the region of
interest1–3 or could be a sum over the number of rare vari-
ants that a subject possesses across that region.4–6 Other
tests that remain powerful when testing regions contain-
ing risk and protective rare variants include the replica-
tion-based test (RBT),7 the C-alpha test,8 and the weighted
haplotype and imputation-based test (WHaIT),9 among
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The AmericAn open issue with rare-variant association tests is their
validity in the presence of confounders such as population
stratification. Confounding from population stratification
occurs when genetic variation is correlated with varia-
tion in disease risk across latent subpopulations or
geographic gradients. This confounding is likely to arise
in association studies of rare variants because such variants
might be unique to a particular ancestral group.14,15 Like
common-variant tests employed in GWASs, certain rare-
variant tests like SKAT12 and others implemented in a
logistic-regression framework2,5,13 can incorporate sum-
mary measures of such variables as covariates. Unfortu-
nately, many other rare-variant association tests that exist
today are implemented in statistical frameworks that
do not allow such straightforward corrections for con-
founders. These include the RBT method,7 which creates
a statistic that detects enrichment of rare variants in cases
versus controls and vice versa and that can also incorpo-
rate adaptive weights, and the C-alpha test,8 which uses
a general homogeneity score statistic16 to test whether
the variance in the proportion of cases that possess rare
variants within a region differs from the expected bino-
mial distribution if all variants are neutral. Many other
rare-variant tests that do not correct for covariates also
exist.4,9,17–20
In addition to those rare-variant tests that cannot
directly adjust for confounders, there are other rare-
variant tests that offer only limited mechanisms to cor-
rect for such variables. One such example is the vari-
able-allele-frequency threshold test,3 which proposes2Department of Biostatistics and Bioinformatics, Emory University, Atlanta,
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Table 1. Sampling a Permuted Data Set
j ¼ 1 j ¼ 2 . j ¼ N Total
Case rk1 rk2 . rkN N1
Control 1 rk1 1 rk2 . 1 rkN N0
Total 1 1 . 1adjusting for covariates by the replacement of disease-
outcome variables in the test statistic with residuals
from a regression analysis of disease outcome on covari-
ates under a linear model. Such a strategy is not ideal
because studies have shown that applying a linear model
to binary disease-outcome data can lead to an inap-
propriate correction for confounding.21–23 Another test
with restricted ability to correct for confounders is the
cumulative minor-allele test (CMAT),6 which allows
for the adjustment of a single categorical covariate.
Such an adjustment will be insufficient if there is a
need to model multiple continuous covariates, such as
summary ancestry measures based on significant eigen-
vectors from a principal-component analysis of genome-
wide SNP data.
For case-control studies, we propose a method that
enables the adjustment of any association test, including
the rare-variant association tests discussed previously, for
an arbitrary number of categorical and continuous con-
founding covariates. These covariates can include sum-
mary measures of ancestry to correct for confounding
due to population stratification. Our strategy involves a
permutation procedure that repeatedly shuffles the disease
outcomes of study participants in a way that generates
permuted (replicate) data sets with the same extent of con-
founding found in the original data set. The distribution of
any test statistic, calculated with these replicate data sets, is
a valid null distribution for the test statistic. Whereas other
rare-variant tests (including the RBT, CMAT, and WHaIT)
already use permutations to establish significance thresh-
olds, such permutations are performed by random shuf-
fling of case or control status among individuals; this shuf-
fling does not preserve the confounding present in the
data set and thereby invalidates the use of the distribution
of permuted statistics for inference when confounding
exists.
To implement our approach, we first model the odds
of disease given confounding covariables (typically by
using logistic regression). We then use Fisher’s noncentral
hypergeometric distribution24 to resample disease status
such that the odds of a subject being selected as a case
are equal to his or her odds of disease conditional on
confounder variables (which we previously defined as the
stratification score in Epstein et al.25). The sampling is
carried out with the open source R package Biase-
dUrn.26,27 Using simulated sequence data, we apply our
permutation strategy to three existing rare-variant tests
(RBT, CMAT, and C-alpha) and show that it corrects for
confounding due to population stratification that would
otherwise inflate the size of these rare-variant statistics.
In addition, we show that even the standard single-locus
tests commonly used for analyzing GWASs might benefit
from our approach when the MAF is small enough that
only a few risk alleles are observed in the population. We
also illustrate the approach with an application to
sequence data from the Dallas Heart Study of energy
metabolism traits.28,29216 The American Journal of Human Genetics 91, 215–223, August 1Material and Methods
We assume a case-control study with N1 case participants and
N0 control participants and let N ¼ N0 þN1. For j ¼ 1; :::;N, we
let Dj indicate the j
th study participant’s disease status for which
Dj ¼ 1 represents a case participant and Dj ¼ 0 represents
a control participant. For the jth study participant, we let Cj be
the covariate vector that we will adjust for when evaluating
the relationship between rare variants and disease outcome
by using an appropriate test statistic. The vector Cj can include
summary measures of ancestry, such as eigenvectors from
principal-component analysis30,31 or spectral-graph analysis32
of GWAS SNP data. Additionally, Cj can include other poten-
tial confounders, such as age, smoking status, and body mass
index (BMI).
We use permutation to establish the significance of an observed
association between genetic variants and disease status. If con-
founding exists, then certain subjects will have greater odds of
being a case than will other subjects even after differences in
causal risk factors are accounted for. Therefore, we propose
sampling a permuted data set in such a way that the odds of
a subject being selected as a case are equal to his or her odds of
disease conditional on confounder variables. For permutation
k, we let rk ¼ ðrk1; rk2;.; rkNÞT be the N-dimensional vector whose
jth component is 1 if the jth study participant is selected as a case
and 0 if the participant is selected as a control. On the basis of
the study design, each rk will have N1 components valued at 1
and N0 components valued at 0. As shown in Table 1, rk corre-
sponds to the vector of cell occupation counts for the first row
of the table given that all row and column marginal totals are
fixed. Thus, the distribution of rk is governed by a multivariate
hypergeometric distribution.24 Therefore, we sample rk by using
Fisher’s noncentral hypergeometric distribution with noncentral-
ity parameter bq ¼ ðbq1; bq2;.; bqNÞ, where bqj is subject j’s estimated
odds of disease conditional on confounder variablesCj (previously
defined as the stratification score25).
A key aspect of our approach is that the confounding role of
covariates is maintained in each permuted data set even though
the association between risk genotypes (or, more generally, expo-
sure) and disease is broken. Recall that a covariate is a confounder
if it influences both genotype and disease. Because we reassign
only disease status, any relationship between confounding cova-
riates and genotype found in the original data is maintained in
each permutation data set. Furthermore, sampling from Table 1
with Fisher’s noncentral hypergeometric distribution with each
participant’s odds of disease qj given covariates Cj maintains
the relationship between confounding covariates and disease
status. In particular, the odds that individual j is chosen to be a
case is qj. However, any association between genotype and
disease is broken because genotype is not considered in the calcu-
lation of the stratification score qj or in the resampling of disease
status.0, 2012
We estimate bqj with the logistic regression model
log

P

Dj ¼ 1 jCj

P

Dj ¼ 0 jCj
hlogqj ¼ aþ gT$Cj; (Equation 1)
where a is an intercept and g is a vector of disease-risk parameters
corresponding to the elements in Cj. We use the maximum-
likelihood estimates of these parameters to construct the esti-
mated odds of disease bqj for subject j as
bqj ¼ expba þ bgT$Cj: (Equation 2)
Using bqj in Equation 2, we construct the probability mass func-
tion of Fisher’s noncentral hypergeometric distribution as
f

rk; bq;N1 ¼ g

rk; bqP
s˛X
g

s; bq; (Equation 3)
where gðrk; bqÞ ¼QNj¼1bqrkjj and X denotes the set of all possible rk
configurations consistent with Table 1. We observe that
f ðrk; bq;N1Þ in Equation 3 does not depend on ba in Equation 2
because the intercept cancels from numerator and denominator.
We point out that, within Cj, specific covariates that do not
predict disease status should have little impact on bqj because their
disease-risk parameters g should be small. Note that use of the
estimated odds (Equation 2) in place of the true odds is justified
given that our method can be considered as a type of parametric
bootstrap. Specifically, our sampling procedure can be thought of
as a bootstrap in which we prospectively assign each participant
a disease outcome on the basis of the logistic model (Equation
1) but then reject all data sets that do not contain N1 case and
N0 control participants.
Up until now, we have avoided specification of an alternate
hypothesis so that the replicate data sets we generate can be
used for any hypothesis test provided that the composite null
hypothesis (Equation 1) is correctly specified. If we are willing to
assume a parametric alternative hypothesis, we can exploit the
connection between our resampling approach and the parametric
bootstrap to generate replicate data sets under a specified alterna-
tive hypothesis. For example, we can assume that
log

P

Dj ¼ 1 jGj;Cj

P

Dj ¼ 0 jGj;Cj
hlogqj ¼ aþ b$Gj þ gT$Cj;
(Equation 4)
where Gj counts the number of minor alleles found at a risk locus.
Although standard asymptotic methods can be used for making
inference about b, we can question these methods when the
MAF of the variant is less common (<5%).
To generate a resampling-based confidence interval for ðbb  bÞ
under the alternative hypothesis (Equation 4), we first estimate
coefficients a, g, and b. We then use these estimates in Equation
4 to estimate bqj and then use these estimates of qj to generate
replicates as described previously. We then fit Equation 4 to each
replicate data set and collect bbr , the b estimate obtained from
the rth replicate. Because these replicates correspond to a para-
metric bootstrap sample in which all data sets that do not have
N1 case and N0 control participants are rejected, we can base infer-
ence on the observed distribution of the bbr values. For example, we
can construct a confidence interval for bb by using the quantiles of
the resampling distribution of bbr . Other bootstrap-based confi-
dence regions described in Efron and Tibshirani33 can also be
calculated.The AmericSoftware
We generated random variates from Fisher’s noncentral hypergeo-
metric distribution by using the R package BiasedUrn created
by Fog.26 The name ‘‘Biased Urn’’ refers to a related use of Fisher’s
multivariate hypergeometric distribution in an urn-model pro-
blem in which each ofN balls has a specified odds of being selected
and in which we sample N1 of these balls without replacement. As
distributed in the Comprehensive R Archive Network (CRAN), the
BiasedUrn package has set the maximum number of columns in
Table 1 to 32. So that the package is amenable for the sample sizes
expected from resequencing studies, the package is recompiled so
that it can generate permutation data sets for any case-control
study in which N % 10,000. On our website, we provide instruc-
tions on how to recompile and install this package with the
increased value for N (see Web Resources). We also provide sample
R code implementing the approach in Appendix A. Because we use
the R package BiasedUrn for calculations involving Fisher’s
noncentral hypergeometric distribution, we refer to our sampling
procedure as biased urn sampling throughout the remainder of the
paper.Results
Biased Urn Sampling Preserves Structure in the
Original Data Set
We first performed a proof-of-principle simulation on the
basis of an existing GWAS to ensure that our proposed
biased urn sampling strategy with Fisher’s noncentral
hypergeometric distribution would preserve the structure
present within a data set (such structure is not preserved
with random [naı¨ve] permutations.) We used data from
a case-control GWAS of African American subjects with
schizophrenia (these data are available for download
from the database of Genotypes and Phenotypes
[dbGaP]34 [see Web Resources and Acknowledgments]).
The GWAS data set initially consisted of data from 921
case and 954 control participants genotyped for 845,814
SNPs on the Affymetrix 6.0 platform. After we used the
PLINK software package35 to implement quality-control
procedures similar to those described in Fellay et al.,36
our final sample consisted of data from 907 case and 937
control participants genotyped for 808,169 SNPs. We
then used a reduced set of 41,182 SNPs in approximate
linkage equilibrium (pairwise r2 % 0.04 as determined by
PLINK) to infer eigenvectors from principal-component
analysis;31 these eigenvectors serve as summary measures
of ancestry. On the basis of the principal-component anal-
ysis, we used Tracy-Widom statistics to identify eight
eigenvectors that were significant at level a ¼ 0.01.
We fit the logistic regression model (Equation 1) to our
sample of 907 cases and 937 controls, and we let Cj repre-
sent the vector of the eight significant eigenvectors for
study participant j. The maximum-likelihood estimates ofbg ¼ ðbg1; bg2;.; bg8Þ are shown in the second column of
Table 2. We next examined whether permuted data sets
generated with our biased urn sampling procedure main-
tained the structure found within the original case-control
data set. We generated a permuted data set by using ouran Journal of Human Genetics 91, 215–223, August 10, 2012 217
Table 2. Regression Coefficient Estimates Under Biased Urn and
Random Permutation Schemes
Original Data
Permutation Scheme
Biased Urn Random
Mean (SD) Mean (SD)
g1 8.39 8.47 (2.02) 0.06 (2.03)
g2 1.41 1.44 (2.14) 0.08 (2.03)
g3 2.13 2.28 (2.00) 0.11 (2.04)
g4 4.86 4.96 (2.05) 0.09 (2.03)
g5 0.88 0.93 (2.02) 0.08 (2.02)
g6 0.69 0.80 (2.09) 0.01 (2.03)
g7 1.22 1.24 (2.01) 0.00 (2.04)
g8 0.76 0.80 (1.99) 0.03 (1.96)
The results for each permutation scheme are based on 1,000 permutations of
the data set. The following abbreviation is used: SD, standard deviation.
Table 3. Type-I Error Results Under Confounding for 10 kb
Regions
Test
Odds Ratio
of Disease
(YRI versus
CEU)
a ¼ 0.05 a ¼ 0.005
Biased Urn Random Biased Urn Random
CMAT 1 0.0521 0.0511 0.0046 0.0045
2 0.0450 0.0850 0.0047 0.0123
4 0.0485 0.1607 0.0053 0.0503
8 0.0551 0.2366 0.0058 0.1004
RBT 1 0.0469 0.0468 0.0043 0.0042
2 0.0487 0.0591 0.0045 0.0066
4 0.0501 0.0962 0.0055 0.0169
8 0.0546 0.1994 0.0055 0.0463
C-alpha 1 0.0491 0.0542 0.0043 0.0051
2 0.0460 0.1712 0.0049 0.0364
4 0.0453 0.4890 0.0042 0.2251
8 0.0527 0.7603 0.0055 0.5011
These results are based on 10,000 replicates each assuming 300 cases and 300
controls. The significance of each replicate was established with 5,000 permu-
tations. The following abbreviations are used: YRI, Yoruba in Ibadan, Nigeria;
CEU, Utah residents with ancestry from northern and western Europe from
the CEPH collection; CMAT, cumulative minor-allele test; and RBT, replica-
tion-based test.biased urn sampling procedure and then refit the logistic
regressionmodel (Equation 1) to the new data set to obtain
a new estimate of g. We repeated this process 1,000 times
and recorded the mean value of g across the permuted
data sets in the third column of Table 2. The results clearly
show that permuted data sets generated with our biased
urn procedure maintain the same population structure
found within the original data set; however, when we
repeated the same analysis by using the standard approach
of randomly permuting the disease status without regard
for confounding, we saw that the structure present in the
case-control sample was not preserved in the permuted
data sets (see fourth column of Table 2). This confirms
that the use of random permutations for assessing the
significance of rare-variant association tests like RBT and
WHaIT, which ignore confounders, could lead to erro-
neous inference if the observed association is due to con-
founding in the original case-control sample.
Simulations to Assess Validity of Rare-Variant Tests in
the Presence of Confounding
We compared the performance of the biased urn sampling
procedure with that of random permutations on different
rare-variant tests by using simulated resequencing data
sets that were subjected to confounding arising from pop-
ulation stratification. We used the coalescent simulator
cosi37 to produce large sets of haplotypes (ranging from
10 kb to 100 kb) whose variation patterns mimicked those
observed in HapMap YRI (Yoruba in Ibadan, Nigeria)
and CEU (Utah residents with ancestry from northern
and western Europe from the CEPH collection) samples.
Randomly pairing haplotypes to form diplotypes, we
prospectively generated case-control data sets in which
a subject’s odds of disease were a function of the average
percentage of African ancestry across the region, and we
thereby induced confounding. We assumed an overall
disease prevalence of 0.01. We considered both discrete218 The American Journal of Human Genetics 91, 215–223, August 1population models that treated the YRI and CEU haplo-
types as separate groups and admixture models that
created haplotypes that were a mixture of YRI and CEU
ancestry. We generated admixed haplotypes by using the
model of Price et al.;38 for a given haplotype, this model
assumes crossover events occurring after initial admixture
by using an exponential distribution with parameter l
(corresponding to the number of generations since initial
admixture; we assumed this value to be 6). These crossover
events divide the haplotype into distinct segments. With
probability t, we filled a segment with the corresponding
segment from a European haplotype; otherwise, we filled
it with the corresponding segment from an African haplo-
type. t was sampled from a Beta(3,12) distribution.39
For each simulated data set, we applied the CMAT,6 RBT,7
and C-alpha8 test to test for association between disease
and the rare variants (defined as those variants with
a sample MAF threshold < 5%) within the region. For
each test, we first established significance by using 5,000
random permutations that did not adjust for confounding
due to population stratification. Next, we established the
significance of the test by using 5,000 data sets generated
with biased urn sampling that adjusted for this confound-
ing. To do this, we simulated genotype data for each
subject on at least 10,000 SNPs that were selected from
HapMap and showed marked allele-frequency differences
between HapMap YRI and CEU samples. We then con-
structed principal components30,31 for each subject on
the basis of the SNP data and used them to construct the0, 2012
Table 4. Type-I Error Results Under Confounding for 100 kb
Regions
Test
Odds Ratio
of Disease
(YRI versus
CEU)
a ¼ 0.05 a ¼ 0.005
Biased
Urn Random
Biased
Urn Random
CMAT 1 0.0466 0.0482 0.0045 0.0048
2 0.0474 0.1040 0.0048 0.0192
4 0.0480 0.2308 0.0050 0.0868
8 0.0544 0.3035 0.0052 0.1439
RBT 1 0.0477 0.0497 0.0048 0.0053
2 0.0445 0.0691 0.0046 0.0080
4 0.0461 0.1463 0.0042 0.0308
8 0.0515 0.3986 0.0057 0.1406
C-alpha 1 0.0440 0.0501 0.0044 0.0049
2 0.0402 0.2834 0.0040 0.0727
4 0.0410 0.7962 0.0050 0.5049
8 0.0422 0.9771 0.0038 0.8729
These results are based on 10,000 replicates each assuming 300 cases and 300
controls. The significance of each replicate was established with 5,000 permu-
tations. The following abbreviations are used: YRI, Yoruba in Ibadan, Nigeria;
CEU, Utah residents with ancestry from northern and western Europe from
the CEPH collection; CMAT, cumulative minor-allele test; and RBT, replica-
tion-based test.
Table 5. Power Results for 10 kb Regions
Test
Permutation
Scheme
Relative Risk of Rare Variant
1.5 2.0 2.5
CMAT Biased urn 0.135 0.244 0.290
Random 0.141 0.241 0.289
RBT Biased urn 0.144 0.263 0.373
Random 0.144 0.273 0.383
C-alpha Biased urn 0.267 0.552 0.735
Random 0.279 0.572 0.754
Results assume 300 cases and 300 controls. Results were evaluated at a ¼ 0.05
and are based on 1,000 replicates. The significance of each replicate was estab-
lished with 5,000 permutations. Simulations assumed no confounding due to
population stratification. Ten percent of rare variants (MAF % 1%) were
assumed to be causal in the region. Each causal rare variant was assumed to
have an identical relative-risk value. For the RBT, we tested a one-sided hypoth-
esis of excess rare variants in cases compared to controls. The following
abbreviations are used: CMAT, cumulative minor-allele test; and RBT, replica-
tion-based test.stratification score in Equation 2; we then used this strati-
fication score within the biased urn procedure in Equa-
tion 3. We also investigated similar sampling based on
known ancestry.
Table 3 provides empirical type-I error rates for the
CMAT, RBT, and C-alpha test for 10 kb regions on the basis
of biased urn and random permutation procedures,
whereas Table 4 provides such rates for 100 kb regions.
For each table, the results show that biased urn sampling
and random permutations both maintain the appropriate
significance level when no confounding exists within the
simulated data sets (the odds ratio of African to European
ancestry is 1). However, when we induce confounding in
the simulated data sets (when the odds ratio of African to
European ancestry > 1), we see that biased urn sampling
maintains appropriate type-I error, whereas random
permutations yield inflated size. This inflation increases
with the degree of confounding. These results are based
on simulations under discrete population models; we see
similar findings for admixture models (results not shown).
To ensure that biased urn sampling’s preservation of
type-I error under confounding did not reduce power, we
performed a simulation under an alternative model, in
which we assumed stratification but no confounding due
to stratification in samples (by assuming the odds ratio
of African to European ancestry was 1). Within a simu-
lated region, we assumed that 10% of variants with a
MAF < 0.01 were causal and that each variant indepen-
dently increased disease risk under a log-additive model;
we assumed that the relative risk of each causal variantThe Americwas identical. Table 5 provides power results for biased
urn sampling and random permutations for different
values of relative risk. These results show that the power
of biased urn and random permutations are quite similar
in these situations, suggesting that biased urn will yield
results analogous to random permutations when con-
founding is absent, whereas the procedure has appropriate
control of size when confounding is present.
Resampling-Based Confidence Intervals of Variant
Risk Estimates
For less-common variants, we examined the confidence
intervals of risk estimates based on our biased urn sam-
pling under the alternative hypothesis specified in
Equation 4 and compared such intervals to those derived
on the basis of asymptotic theory. Assuming a disease prev-
alence of 0.01, we prospectively generated 5,000 data sets
comprising 300 cases and 300 controls as described previ-
ously. We assumed a risk variant with a MAF of 0.02 (and
an effect size of b ¼ 1 on the log-disease-odds scale) and
further induced confounding by letting the disease odds
ratio of each African chromosome be 4. For each data set,
we calculated a 95% resampling-based confidence interval
for the variant risk estimate by using 10,000 biased urn
replicates generated from Equation 3 on the basis of the
model in Equation 4. We calculated resampling-based
confidence intervals various ways, including by using the
quantiles of the resampled estimates and a bias-corrected
calculation.40 We also calculated an asymptotic 95% confi-
dence interval for the estimate of the variant effect on the
basis of a standard logistic-regression model adjusting for
the effect of the confounding.
Our simulations revealed that the resampling-based
confidence intervals had appropriate coverage and were
smaller in magnitude than the corresponding asymptotic
interval. We observed that our 95% resampling-basedan Journal of Human Genetics 91, 215–223, August 10, 2012 219
Table 6. CMAT Analysis of Sequence Data from the Dallas Heart
Study
Trait Gene
p Value of CMAT
Random
Permutations
Biased Urn
Permutations
Triglycerides ANGPTL3 <0.0001 0.0141
ANGPTL4 <0.0001 0.0015
ANGPTL5 0.0201 0.0974
BMI ANGPTL3 0.5930 0.7418
ANGPTL4 0.6984 0.7058
ANGPTL5 0.0077 0.0301
Biased urn permutations are corrected for effects of age, gender, and race.
Analysis is based only on nonsynonymous variants in each gene. Each p value
is based on 10,000 permutations. The following abbreviations are used: CMAT,
cumulative minor-allele test; and BMI, body mass index.
Table 7. RBT Analysis of Sequence Data from the Dallas Heart
Study
Trait Gene
p Value of RBT
Random
Permutations
Biased Urn
Permutations
Triglycerides ANGPTL3 0.0006 0.0126
ANGPTL4 <0.0001 0.0034
ANGPTL5 0.0231 0.1102
BMI ANGPTL3 0.5174 0.6890
ANGPTL4 0.9180 0.9348
ANGPTL5 0.0046 0.0170
Biased urn permutations are corrected for effects of age, gender, and race.
Analysis is based only on nonsynonymous variants in each gene. Each p value
is based on 10,000 permutations. The following abbreviations are used: RBT,
replication-based test; and BMI, body mass index.confidence interval calculated with quantiles had appro-
priate coverage of 0.949. The coverage of the asymptotic
95% confidence interval was also appropriate (0.953);
however, the resampling-based confidence intervals were
somewhat shorter than the asymptotic intervals and
shifted away from the null. We found that the mean 95%
resampling-based confidence interval calculated with
quantiles was (0.122, 2.120), whereas the corresponding
asymptotic confidence interval was wider at (0.029,
2.087) and further contained the null value of 0. We
observed similar trends for 99% confidence intervals
(results not shown).
Application to the Dallas Heart Study
The Dallas Heart Study is a multiethnic population-based
study that previously examined the relationship between
sequence variation within ANGPTL3 (MIM 604774),
ANGPTL4 (MIM 605910), and ANGPTL5 (MIM 607666)
and various quantitative metabolism-related traits.28,29
Coding regions of these three genes were sequenced in
a group of 3,476 subjects (1,830 African Americans, 1,045
European Americans, and 601 Hispanics). In this applica-
tion, we studied two metabolic outcomes: triglyceride
levels and BMI. Prior to analysis, we first removed data
from 216 subjects who were being treated with statins.
Then, for each outcome, we selected subjects in the top
and bottom 20% of the outcome distribution (after
removing subjects with missing outcomes) to mimic
a case-control study design. To study triglycerides, we ob-
tained 570 case and 570 control participants. To study
BMI, we obtained 563 case and 563 control participants.
We applied the CMAT6 to test for association between
rare nonsynonymous (NS) variants in ANGPTL3,
ANGPTL4, and ANGPTL5 and our case-control representa-
tions of triglycerides and BMI. Within the triglyceride
sample, we found 36 NS variants in ANGPTL3, 39 in
ANGPTL4, and 27 in ANGPTL5. Within the BMI sample,
we saw 36 NS variants in ANGPTL3, 38 in ANGPTL4, and220 The American Journal of Human Genetics 91, 215–223, August 127 in ANGPTL5. For each CMAT statistic, we established
significance by using both random permutations and
biased urn sampling that adjusted for the effects of age,
gender, and race. The results of these analyses are shown
in Table 6. The results clearly show that the CMAT p values
based on random permutations are smaller than their
corresponding p values based on biased urn sampling ad-
justing for confounders. Notably, failing to adjust for con-
founders appears to lead to a spurious association between
rare NS variants in ANGPTL5 and triglyceride levels. Subse-
quent investigation revealed that, as expected, race was
a confounder because it was associated with both case-
control status (p< 0.0001) and the presence of rare NS vari-
ants in ANGPTL5 (p ¼ 0.0002). We also repeated the anal-
yses by using a two-sided version of the RBT7 and observed
similar findings and trends (Table 7). We also applied the
C-alpha8 test and observed similar trends with the excep-
tion that there was no evidence of association between
rare NS variants in ANGPTL5 and either BMI or triglyceride
levels with the use of either random permutations or
biased urn sampling (Table 8).Discussion
In this article, we propose a simple biased urn sampling
procedure (based on the use of Fisher’s noncentral hyper-
geometric distribution) that resamples subjects under the
null hypothesis of no association in a way that preserves
the confounding present in the actual data set. This proce-
dure is particularly valuable for rare-variant association
tests, many of which are not easily adjusted for probable
confounders like population stratification and whose
applicability is thus limited in case-control resequencing
studies. With a combination of simulated and real data
sets, we have illustrated how our approach corrects for con-
founding in three common rare-variant association tests.
In addition, we have shown how resampling-based0, 2012
Table 8. C-Alpha Analysis of Sequence Data from the Dallas Heart
Study
Trait Gene
p Value of C-Alpha Test
Random
Permutations
Biased Urn
Permutations
Triglycerides ANGPTL3 <0.0001 0.0010
ANGPTL4 0.0001 0.0363
ANGPTL5 0.1572 0.2043
BMI ANGPTL3 0.9168 0.9814
ANGPTL4 0.8314 0.8472
ANGPTL5 0.2310 0.2872
Biased urn permutations are corrected for effects of age, gender, and race.
Analysis is based only on nonsynonymous variants in each gene. Each p value
is based on 10,000 permutations. The following abbreviation is used: BMI,
body mass index.confidence intervals of risk estimates for individual suscep-
tibility variants can be calculated when a parametric alter-
native hypothesis is specified.
Our procedure adjusts rare-variant association testing for
confounders by using permutation, which is a common re-
sampling procedure used for statistical inference. Another
resampling procedure called the parametric bootstrap41
has been proposed by Lin and Tang13 for adjusting
logistic-regression-based rare-variant association tests for
the effects of covariates. The parametric bootstrap of Lin
andTangcreates replicatedata sets fromaprospectivemodel
in which the disease outcome of each subject in a data set is
generated on the basis of the subject’s probability of disease
conditional on covariates (which we write as bqj=ð1þ bqjÞ by
using the notation in Equation 2). For logistic regression,
it is known that a retrospective analysis of such prospec-
tively generated data can give the same results (except for
the intercept, which is typically not of interest). Further-
more, it is also known that logistic regression is indifferent
to whether row and/or column totals in Table 1 are held
fixed. However, because the parametric bootstrap does
not preserve the number of cases and controls within
each generated data set, it is unclear whether it can be
applied to tests that are not based on logistic regression.
Our biased urn procedure, on the other hand, possesses
the useful feature that it preserves the number of cases
and controls within each sample by design and so corre-
sponds to retrospective sampling. For this reason, it can
be applied to any test that is appropriate for case-control
data as long as a valid model for the stratification score is
used. Such preservation of case-control numbers in repli-
cate data sets is particularly valuable for exome-sequencing
studies of Mendelian traits, studies which often possess
only a handful of cases for analysis.19 Finally, we note
that we could apply the parametric bootstrap in such
a manner that we only accept data sets that preserve the
original number of cases and controls, but such a procedure
will be much less computationally efficient than biased
urn sampling. In our simulations, we observed that thisThe Americapproach required ~253 more computation time than
biased urn sampling across different sample sizes.
Our biased urn sampling is implemented in a recompiled
version of the R BiasedUrn package. Appendix A provides
sample code for applying the approach. The computation
time required for generating permuted data sets depends
on sample size but is reasonable even for studies composed
of thousands of participants. On a single 3.20 GHz Intel
Xeon central processing unit running Windows XP on
a Dell PowerEdge 2950 server with 2 GB of random-access
memory, the generation of 10,000 permuted data sets for
sample sizes of 1,000, 5,000, and 10,000 required ~30 s,
~8 min, and ~30 min of computation time, respectively.
Furthermore, the process can be implemented in parallel
for the reduction of computation time.Appendix A: Sample R Code for Implementing
Biased Urn Sampling Procedure
library(‘BiasedUrn’) #load (modified) package
# Assume one has already scanned in required data set.
# dis: array of disease outcomes (1 affected, 0 unaffected) for N subjects
# z: covariate matrix of dimension N 3 C
n.case < - sum(dis) # number of cases
n.perm < - 1000 # number of permutations
# step 1: fit logistic-regression model in Equation 1
model < - glm (dis ~z, family= binomial())
# step 2: construct estimated disease odds in Equation 2
d.odds < - exp (model$linear.predictors)
# step 3: generate N x n.perm matrix of permuted data sets
m1 < - c(rep(1, length(dis)))
perm.hg < - rMFNCHypergeo(n.perm, m1, n.case, d.odds)Acknowledgments
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Web Resources
The URLs for data presented herein are as follows:
BiasedUrn package in CRAN, http://cran.r-project.org/web/
packages/BiasedUrn/index.html
cosi, http://www.broadinstitute.org/~sfs/cosi/
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Epstein Software, http://www.genetics.emory.edu/labs/epstein/
software
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